|
1
|
Bardag Gorce F, Al Dahan M, Narwani K, Terrazas J, Ferrini M, Calhoun CC, Uyanne J, Royce-Flores J, Crum E, Niihara Y. Human Oral Mucosa as a Potentially Effective Source of Neural Crest Stem Cells for Clinical Practice. Cells 2023; 12:2216. [PMID: 37759439 PMCID: PMC10526281 DOI: 10.3390/cells12182216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 08/28/2023] [Accepted: 08/29/2023] [Indexed: 09/29/2023] Open
Abstract
We report in this study on the isolation and expansion of neural crest stem cells (NCSCs) from the epithelium of oral mucosa (OM) using reagents that are GMP-certified and FDA-approved for clinical use. Characterization analysis showed that the levels of keratins K2, K6C, K4, K13, K31, and K15-specific to OM epithelial cells-were significantly lower in the experimental NCSCs. While SOX10 was decreased with no statistically significant difference, the earliest neural crest specifier genes SNAI1/2, Ap2a, Ap2c, SOX9, SOX30, Pax3, and Twist1 showed a trend in increased expression in NCSCs. In addition, proteins of Oct4, Nestin and Noth1 were found to be greatly expressed, confirming NCSC multipotency. In conclusion, our study showed that the epithelium of OM contains NCSCs that can be isolated and expanded with clinical-grade reagents to supply the demand for multipotent cells required for clinical applications in regenerative medicine. Supported by Emmaus Medical Inc.
Collapse
Affiliation(s)
- Fawzia Bardag Gorce
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
- Division of Oral & Maxillofacial Surgery and Hospital Dentistry, Department of Surgery Harbor UCLA Medical Center, Torrance, CA 90502, USA
- Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
| | - Mais Al Dahan
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
- Division of Oral & Maxillofacial Surgery and Hospital Dentistry, Department of Surgery Harbor UCLA Medical Center, Torrance, CA 90502, USA
| | - Kavita Narwani
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
| | - Jesus Terrazas
- Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
| | - Monica Ferrini
- Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
| | - Colonya C. Calhoun
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
- Department of Surgery, UCLA, David Geffen School of Medicine, Los Angeles, CA 90095, USA
- UCLA School of Dentistry, Los Angeles, CA 90095, USA
- Department of Oral & Maxillofacial Surgery and Hospital Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI 48109, USA
| | - Jettie Uyanne
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
- Division of Oral & Maxillofacial Surgery and Hospital Dentistry, Department of Surgery Harbor UCLA Medical Center, Torrance, CA 90502, USA
- Herman Ostrow School of Dentistry of USC, Los Angeles, CA 90089, USA
| | - Jun Royce-Flores
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
- Division of Oral & Maxillofacial Surgery and Hospital Dentistry, Department of Surgery Harbor UCLA Medical Center, Torrance, CA 90502, USA
- UCLA School of Dentistry, Los Angeles, CA 90095, USA
| | - Eric Crum
- Division of Oral & Maxillofacial Surgery and Hospital Dentistry, Department of Surgery Harbor UCLA Medical Center, Torrance, CA 90502, USA
- Department of Surgery, UCLA, David Geffen School of Medicine, Los Angeles, CA 90095, USA
- UCLA School of Dentistry, Los Angeles, CA 90095, USA
| | - Yutaka Niihara
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA (Y.N.)
- Emmaus Medical, Inc., Torrance, CA 90503, USA
| |
Collapse
|
|
2
|
Kent I, Freund MR, Agarwal S, Wexner SD. The application of regenerative medicine in colorectal surgery. Surgery 2021; 171:867-872. [PMID: 34649714 DOI: 10.1016/j.surg.2021.08.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2021] [Revised: 07/12/2021] [Accepted: 08/17/2021] [Indexed: 02/08/2023]
Abstract
Tissue reconstruction and regeneration represent one of the greatest challenges in any surgical field. Regenerative medicine combined with stem cell-based therapy is a novel and promising field of medicine. Stem cells possess the ability to differentiate into specialized cells and to decrease inflammation and therefore can play a role in repair or regeneration of damaged tissues. Colorectal surgery often deals with infected, poorly vascularized, radiated, and inflamed tissue, as well as instances where imperfect healing might have grave implications. This problem has led researchers to study utilizing stem cells in many colorectal conditions, such as anastomotic healing, perianal fistulae, rectovaginal fistulae, anal fissure, and fecal incontinence. The purpose of this review was to discuss prominent studies that explored stem cells utilization in treating different colorectal pathologies.
Collapse
Affiliation(s)
- Ilan Kent
- Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. https://twitter.com/ilan_kent
| | - Michael R Freund
- Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. https://twitter.com/mikifreund
| | - Samir Agarwal
- Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. https://twitter.com/SamAgarwalMD1
| | - Steven D Wexner
- Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL.
| |
Collapse
|